Feb. 23: "SARS-CoV-2 evolution during treatment of chronic infection"
Ravindra Gupta is a professor of clinical microbiology at the Cambridge Institute of Therapeutic Immunology and Infectious Disease at the University of Cambridge. He focuses on host-pathogen and drug-pathogen interactions to inform HIV treatment and curative strategies. In particular, this includes in vitro HIV drug resistance to protease inhibitors and its implications for global scale up of antiretroviral therapy, and investigating the details of macrophage infection in clinical isolates.